UNSPSC 51111873: Tamoxifen

This classification denotes a selective estrogen receptor modulator and protein kinase c inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 094ZI81Y45. European Medicines Agency schedules Tamoxifen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10825MIG. Tamoxifen generally arises in the molecular formula C26H29NO.

UNSPSC 51111873 Tamoxifen is a Commodity code covering pharmaceutical supply contracts through state and local cooperative purchasing agreements. The work being solicited involves manufacturers supplying generic pharmaceuticals and over-the-counter products directly to cooperative purchasing vehicles that aggregate demand across multiple state and local government facilities, requiring vendors to maintain National Drug Code (NDC) compliance, certify manufacturing practices under cGMP and the Drug Supply Chain Security Act (DSCSA), and establish pricing relationships with authorized wholesalers using chargeback systems. State procurement offices and multistate cooperative purchasing alliances are the primary issuing bodies, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration's Office of State Procurement serving as the administrator and aggregator for participating state and local jurisdictions across multiple states including Oregon.

MMCAP issued a Request for Proposal (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, establishing multiple contracts effective July 1, 2026. The solicitation weighted evaluation 75 percent on price competitiveness, 10 percent on fixed pricing format, 5 percent each on administrative fee compliance and EDI capability, and 5 percent on agreement to a 3 percent administrative fee. Vendors must carry commercial general liability insurance of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000; maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC); and submit proposals through the ePro procurement system with pricing in Excel spreadsheet format converted to CSV. The contract term is two years for new responders with optional extensions at MMCAP's discretion, and incumbent responders' amendments extend through June 30, 2028.